Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.

Abstract:

:The steady-state pharmacokinetic interaction between nefazodone and cimetidine was evaluated in a three-period crossover study consisting of three treatments of 1 week duration with a 1 week washout between treatments. The 18 healthy, male study subjects received: nefazodone hydrochloride 200 mg twice daily (every 12 h) for 6 days; cimetidine 300 mg four times daily for 6 days; and 200 mg nefazodone hydrochloride twice daily + 300 mg cimetidine four times daily for 6 days. On day 7 of each treatment, only the morning dose was administered. Serial blood samples were collected for pharmacokinetic analysis after drug administration on day 7 of each treatment; blood samples for trough levels (Cmin) to assess attainment of steady state, were also collected just prior to the morning doses on days 2-7 of each study period. Plasma samples were assayed for cimetidine, and nefazodone and its metabolites hydroxynefazodone and m-chlorophenylpiperazine by specific, validated h.p.l.c. methods. Statistical analyses of Cmin data indicated that, regardless of treatment, steady state was achieved for cimetidine by day 2 and for nefazodone and its metabolites by day 3 of multiple dosing, and that there were no significant differences in Cmin levels between treatments. When nefazodone and cimetidine were co-administered for 1 week, no change in steady-state pharmacokinetic parameters for cimetidine, nefazodone or hydroxynefazodone was observed compared with each drug dosed alone.(ABSTRACT TRUNCATED AT 250 WORDS)

journal_name

Br J Clin Pharmacol

authors

Barbhaiya RH,Shukla UA,Greene DS

doi

10.1111/j.1365-2125.1995.tb05771.x

subject

Has Abstract

pub_date

1995-08-01 00:00:00

pages

161-5

issue

2

eissn

0306-5251

issn

1365-2125

journal_volume

40

pub_type

临床试验,杂志文章,随机对照试验
  • Cato Guldberg and Peter Waage, the history of the Law of Mass Action, and its relevance to clinical pharmacology.

    abstract::We have traced the historical link between the Law of Mass Action and clinical pharmacology. The Law evolved from the work of the French chemist Claude Louis Berthollet, was first formulated by Cato Guldberg and Peter Waage in 1864 and later clarified by the Dutch chemist Jacobus van 't Hoff in 1877. It has profoundly...

    journal_title:British journal of clinical pharmacology

    pub_type: 传,历史文章,杂志文章,评审

    doi:10.1111/bcp.12721

    authors: Ferner RE,Aronson JK

    更新日期:2016-01-01 00:00:00

  • Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease.

    abstract:AIMS:To investigate the pharmacokinetics of enterally administered cisapride suspension in young infants being treated for gastro-oesophageal reflux disease. METHODS:Plasma cisapride concentrations in 49 subjects (weight: 825-5010 g; n=108 samples, median two per patient; concentration: 14.8-170 ng ml-1 ) were fitted ...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1046/j.1365-2125.1999.00068.x

    authors: Preechagoon Y,Charles B,Piotrovskij V,Donovan T,Van Peer A

    更新日期:1999-11-01 00:00:00

  • Proof of pharmacology of Org 48775-0, a p38 MAP kinase inhibitor, in healthy volunteers.

    abstract:AIM:To investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the highly selective oral p38alpha/beta mitogen-activated protein (MAP) kinase inhibitor Org 48,775-0 in a first-in-human study. METHODS:In the single ascending dosing (SAD) study, an oral dose of Org 48,775-0 (0.3-600 mg) was evalua...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.14655

    authors: Moerland M,Kales AJ,Broekhuizen K,Nässander U,Nelissen R,de Kam ML,Peeters PAM,Burggraaf J

    更新日期:2020-11-17 00:00:00

  • Plasma digoxin: assay anomalies in Fab-treated patients.

    abstract::Using a variety of radioimmunoassay methods, plasma digoxin concentrations were measured in two patients before and after the administration of ovine Fab antibody fragments to remove the effects of digoxin. Gross method-dependent anomalies in the results due to in vitro drug interaction were observed. More widespread ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1983.tb02194.x

    authors: Gibb I,Adams PC,Parnham AJ,Jennings K

    更新日期:1983-10-01 00:00:00

  • Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.

    abstract::Medroxalol, a new drug which has been reported to possess both alpha- and beta-adrenoceptor antagonist properties, was compared with labetalol in single dose studies in normotensive males. Oral doses of 400 mg of each drug significantly reduced blood pressure, both supine and erect, without significant changes in hear...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1984.tb02391.x

    authors: Elliott HL,McLean K,Meredith PA,Sumner DJ,Reid JL

    更新日期:1984-05-01 00:00:00

  • Optimization of a drug transporter probe cocktail: potential screening tool for transporter-mediated drug-drug interactions.

    abstract:AIMS:Previous pharmacokinetic characterization of a transporter probe cocktail containing digoxin (P-gp), furosemide (OAT1, OAT3), metformin (OCT2, MATE1, MATE2-K) and rosuvastatin (OATP1B1, OATP1B3, BCRP) in healthy subjects showed increases in rosuvastatin systemic exposure compared to rosuvastatin alone. In this tri...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/bcp.13609

    authors: Stopfer P,Giessmann T,Hohl K,Hutzel S,Schmidt S,Gansser D,Ishiguro N,Taub ME,Sharma A,Ebner T,Müller F

    更新日期:2018-09-01 00:00:00

  • Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program.

    abstract::1 To assess the potential hazards of nitrazepam therapy of insomnia in the elderly, adverse reactions to nitrazepam were studied in 2111 hospitalized medical patients who received the drug. 2 Manifestations of unwanted central nervous system (CNS) depression (such as drowsiness or 'hangover') were reported in 49 nitra...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1978.tb01646.x

    authors: Greenblatt DJ,Allen MD

    更新日期:1978-05-01 00:00:00

  • Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma.

    abstract:AIMS:Adenosine monophosphate (AMP) acts indirectly via primed airway mast cells to induce bronchial hyper-responsiveness, which in turn correlates with eosinophilic asthmatic inflammation and atopic disease expression. We evaluated single and short-term dosing effects of a modern histamine H1-receptor antagonist, levoc...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.2004.02110.x

    authors: Lee DK,Gray RD,Wilson AM,Robb FM,Soutar PC,Lipworth BJ

    更新日期:2004-07-01 00:00:00

  • Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.

    abstract:AIMS:To predict the drug interactions of amiodarone and other drugs, the inhibitory effects and inactivation potential for human cytochrome P450 (CYP) enzymes by amiodarone and its N-dealkylated metabolite, desethylamiodarone were examined. METHODS:The inhibition or inactivation potency of amiodarone and desethylamiod...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2125.2000.00134.x

    authors: Ohyama K,Nakajima M,Suzuki M,Shimada N,Yamazaki H,Yokoi T

    更新日期:2000-03-01 00:00:00

  • In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin.

    abstract:AIMS:Canagliflozin is a recently approved drug for use in the treatment of type 2 diabetes. The potential for canagliflozin to cause clinical drug-drug interactions (DDIs) was assessed. METHODS:DDI potential of canagliflozin was investigated using in vitro test systems containing drug metabolizing enzymes or transport...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.13186

    authors: Mamidi RNVS,Dallas S,Sensenhauser C,Lim HK,Scheers E,Verboven P,Cuyckens F,Leclercq L,Evans DC,Kelley MF,Johnson MD,Snoeys J

    更新日期:2017-05-01 00:00:00

  • Inhibitors of imipramine metabolism by human liver microsomes.

    abstract::1. The aromatic 2-hydroxylation of imipramine was studied in microsomes from three human livers. The kinetics were best described by a biphasic enzyme model. The estimated values of Vmax and Km for the high affinity site ranged from 3.2 to 5.7 nmol mg-1 h-1 and from 25 to 31 microM, respectively. 2. Quinidine was a po...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1992.tb04133.x

    authors: Skjelbo E,Brøsen K

    更新日期:1992-09-01 00:00:00

  • Flecainide: single and multiple oral dose kinetics, absolute bioavailability and effect of food and antacid in man.

    abstract::The kinetics of flecainide after single intravenous (2 mg kg-1) and oral (200 mg) dosing, absolute bioavailability, effects of food and aluminium hydroxide on flecainide absorption and steady-state kinetics following twice daily oral dosing (200 mg) have been evaluated in ten healthy subjects. Absolute bioavailability...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1986.tb02892.x

    authors: Tjandra-Maga TB,Verbesselt R,Van Hecken A,Mullie A,De Schepper PJ

    更新日期:1986-09-01 00:00:00

  • Effect of allopurinol on caffeine disposition in man.

    abstract::Caffeine (5 mg kg-1) was administered orally to two healthy, non-smoking subjects on three separate occasions--before, and during therapy with the xanthine oxidase inhibitor allopurinol at doses of either 300 or 600 mg daily. Plasma and urinary levels of methylxanthines, endogenous oxypurines and allopurinol and its m...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1986.tb05222.x

    authors: Grant DM,Tang BK,Campbell ME,Kalow W

    更新日期:1986-04-01 00:00:00

  • Effects of MHRA drug safety advice on time trends in prescribing volume and indices of clinical toxicity for quinine.

    abstract:AIMS:To ascertain the effects of the Medicines and Healthcare products Regulatory Agency's (MHRA) safety update in June 2010 on the volume of prescribing of quinine and on indices of quinine toxicity. METHODS:We analysed quarterly primary care total and quinine prescribing data for England and quinine prescribing volu...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.12130

    authors: Acheampong P,Cooper G,Khazaeli B,Lupton DJ,White S,May MT,Thomas SH

    更新日期:2013-12-01 00:00:00

  • Ipratropium bromide and fenoterol by aerosolized solution.

    abstract::Ipratropium bromide (0.5 mg) and fenoterol (2 mg) produced equivalent peak bronchodilatation between 1 and 2 h after administration to eight patients with chronic partially reversible airways obstruction. The duration of action compared with saline was 6 h for ipratropium and 4 h for fenoterol. Both drugs in combinati...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1982.tb04946.x

    authors: Jenkins CR,Chow CM,Fisher BL,Marlin GE

    更新日期:1982-07-01 00:00:00

  • Influence of various antihypertensive agents on lifespan of renal hypertensive rats.

    abstract::1 Daily treatment of two-kidney clipped renal hypertensive rats with hydrallazine, hydrochlorothiazide (HCTZ) and a new orally active inhibitor of the angiotensin-converting enzyme, captopril (SQ14,225), was correlated with survival rates for up to 9 months. 2 The groups of rats given captopril alone or captopril plus...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1979.tb04696.x

    authors: Horovitz ZP,Antonaccio MJ,Rubin B,Panasevich RE

    更新日期:1979-01-01 00:00:00

  • Antidepressant drugs, convulsions and epilepsy.

    abstract::1 Evidence concerning the convulsant effects of non-monoamine oxidase inhibitor antidepressant drugs has been reviewed. 2 Mianserin is convulsant in therapeutic doses but seizures have not been reported following overdose. 3 The convulsant effects of mianserin are probably no greater than for other non-monoamine oxida...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1983.tb05878.x

    authors: Richens A,Nawishy S,Trimble M

    更新日期:1983-01-01 00:00:00

  • Captopril in essential hypertension.

    abstract::1 Forty-one patients with essential hypertension, stages I, II, and III, were treated with captopril alone or in combination with hydrochlorothiazide. Forty two percent were responsive to captopril alone, while the remaining 58% also required the diuretic. The need for the diuretic was related to the phase of hyperten...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1982.tb02065.x

    authors: Rabinad Estrada E,Ingelmo Morin M,Martinez Amenos A,Alsina J,Balcells Gorina A

    更新日期:1982-01-01 00:00:00

  • Towards a better use of scientific advice for developers of advanced therapies.

    abstract::Scientific advice (SA) is an important tool offered by regulators to help developers generate robust evidence on a medicine's benefits and risks. Drawing on accumulated experience and looking at the SA provided by the European Medicines Agency in 2018 to advanced therapy medicinal products originally developed by publ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.14672

    authors: Tavridou A,Rogers D,Bonelli M,Schiel A,Hidalgo-Simon A

    更新日期:2020-11-25 00:00:00

  • Site of deposition and absorption of an inhaled hydrophilic solute.

    abstract:AIMS:To characterize the absorption kinetics and bioavailability of an inhaled hydrophilic solute deposited at various sites within the airways. METHODS:Nine healthy nonsmokers received one intravenous, one oropharyngeal and two pulmonary doses of technetium-99 m-labelled diethylene triamine pentaacetic acid ((99m)Tc-...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.2006.02835.x

    authors: Bondesson E,Bengtsson T,Nilsson LE,Wollmer P

    更新日期:2007-06-01 00:00:00

  • Concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients--a prescription database study.

    abstract::1. In order to assess the prevalence of concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients, a prescription database study was conducted in the Odense area for a period of 2 years. 2. During the index period 5.12% of the inhabitants purchased major psychotropic drugs. Of these,...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1994.tb04300.x

    authors: Rosholm JU,Hallas J,Gram LF

    更新日期:1994-06-01 00:00:00

  • Drug resistance, inappropriate dosing and non-compliance in hypertensive patients.

    abstract::1 From an understanding of the biological fate and hypotensive effect of debrisoquine (D) we have assessed the relative importance of true drug resistance, inappropriately low dosage and non-compliance as causes of apparent resistance to treatment with this drug. 2 Among 37 hypertensive patients prescribed D, eleven (...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1980.tb01072.x

    authors: Silas JH,Tucker GT,Smith AJ

    更新日期:1980-04-01 00:00:00

  • Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial.

    abstract:AIMS:Breakthrough bleeding or even unwanted pregnancies have been reported in women during concomitant therapy with oral contraceptives and St John's wort extract. The aim of the present study was to investigate the effects of St John's wort extract on oral contraceptive therapy with respect to ovarian activity, breakt...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1365-2125.2003.02005.x

    authors: Pfrunder A,Schiesser M,Gerber S,Haschke M,Bitzer J,Drewe J

    更新日期:2003-12-01 00:00:00

  • Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure.

    abstract:AIMS:In the Swiss heroin substitution trials, patients are treated with self-administered diacetylmorphine (heroin). Intravenous administration is not possible in patients that have venosclerosis. Earlier studies have demonstrated that oral diacetylmorphine may be used, although it is completely converted to morphine p...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.2008.03286.x

    authors: Halbsguth U,Rentsch KM,Eich-Höchli D,Diterich I,Fattinger K

    更新日期:2008-12-01 00:00:00

  • Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial.

    abstract:AIM:We compared the efficacy of melatonin and placebo as adjuvants in the withdrawal of patients from long term temazepam, zopiclone or zolpidem (here 'BZD') use. METHODS:A double-blind, placebo-controlled, randomized trial was conducted in a primary health care outpatient clinic. Ninety-two men or women (≥55 years) w...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/bcp.12294

    authors: Lähteenmäki R,Puustinen J,Vahlberg T,Lyles A,Neuvonen PJ,Partinen M,Räihä I,Kivelä SL

    更新日期:2014-06-01 00:00:00

  • The selectivity of the beta-adrenoceptor for ventilation in man.

    abstract::1 Minute ventilation, alveolar PCO2, CO2 production and heart rate were measured in eight normal subjects before and during infusions of noradrenaline 0.2, 1.0 and 5.0 micrograms min-1 and isoprenaline 0.04, 0.2 and 1.0 microgram min-1. 2 These measurements were repeated after propranolol 3.5 mg, atenolol 8 mg or meto...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1982.tb04961.x

    authors: Butland RJ,Pang JA,Geddes DM

    更新日期:1982-11-01 00:00:00

  • A gastroscopic and pharmacological study of the disintegration time and absorption of pivampicillin capsules and tablets.

    abstract::1 An in vitro investigation showed that pivampicillin tablets disintegrated more rapidly than pivampicillin capsules. This result was demonstrated and confirmed by gastroscopy in a cross-over study in healthy volunteers. 2 There were no differences in serum levels of ampicillin obtained with the two preparations, but ...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1979.tb01008.x

    authors: Hey H,Matzen P,Andersen JT,Didriksen E,Nielsen B

    更新日期:1979-09-01 00:00:00

  • Rate-controlled rectal absorption enhancement of cefoxitin by co-administration of sodium salicylate or sodium octanoate in healthy volunteers.

    abstract::1. The effects of sodium octanoate and sodium salicylate on the rectal absorption of cefoxitin were investigated in healthy volunteers. Drug solutions were given either as a bolus or as a zero-order infusion. 2. On rectal infusion sodium octanoate and sodium salicylate both enhanced mean cefoxitin bioavailability (+/-...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1989.tb05337.x

    authors: Van Hoogdalem EJ,Wackwitz AT,De Boer AG,Cohen AF,Breimer DD

    更新日期:1989-01-01 00:00:00

  • Plasma concentrations and ocular effects of cyclopentolate after ocular application of three formulations.

    abstract::1. Eight volunteers received in randomized order two 30 microliters drops of either 1% w/v cyclopentolate hydrochloride or a corresponding amount of cyclopentolate polygalacturonate in saline or in acetate buffer in one eye. Cyclopentolate concentrations in plasma were measured by a radioreceptor assay. 2. Peak plasma...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1993.tb04173.x

    authors: Lahdes K,Huupponen R,Kaila T,Monti D,Saettone MF,Salminen L

    更新日期:1993-05-01 00:00:00

  • A randomized, double-blind, placebo-controlled trial comparing pethidine to metamizol for treatment of post-anaesthetic shivering.

    abstract::1. Shivering is frequent during the post-anaesthetic recovery period, and there is no clear consensus about the best strategy for its treatment. We tested the efficacy of two commonly used analgesic drugs, pethidine and metamizol. 2. A randomized, double-blind, placebo-controlled clinical trial was performed, includin...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1365-2125.1996.04124.x

    authors: Monsó A,Riudeubas J,Barbal F,Laporte JR,Arnau JM

    更新日期:1996-09-01 00:00:00